- Home
- Companies
- Regenerative Medical Solutions Inc. ...
- News
- NIH/NIDDK Phase 1 SBIR Awarded July ...
NIH/NIDDK Phase 1 SBIR Awarded July 2016
Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells.
-
Most popular related searches
Customer comments
No comments were found for NIH/NIDDK Phase 1 SBIR Awarded July 2016. Be the first to comment!